Literature DB >> 12890821

Hepatosplenic T cell lymphoma with no expression of cytotoxic molecules.

Y Sadahira1, K Notohara, T Manabe.   

Abstract

Hepatosplenic T cell lymphoma is defined as an extranodal and systemic neoplasm derived from cytotoxic T cells. This report describes a postmortem case of T cell lymphoma that showed histological features of hepatosplenic T cell lymphoma but did not express cytotoxic molecules. The patient was a 57 year old man who presented with severe icterus and hepatosplenomegaly, followed by an aggressive clinical course. The liver and spleen were enlarged, weighing 2000 g and 360 g, respectively. Histologically, the liver, spleen, and bone marrow were entirely affected by lymphoma, comprising pleomorphic small and large cells, which displayed sinusoidal infiltration in the liver, diffuse infiltration in the splenic cord, and interstitial/diffuse infiltration with fibrosis in the bone marrow. Lymphoma cells showed positivity for CD3 epsilon, CD8, and CD45RO and clonal rearrangement of the TCRgamma gene by the polymerase chain reaction on paraffin wax embedded sections. However, they were negative for TIA-1 and granzyme B, in addition to betaF1, CD4, and CD56. Few neoplastic cells were stained for Epstein-Barr virus encoded mRNA 1. These findings indicate that this case might represent a variant of hepatosplenic T cell lymphoma despite the absence of cytotoxic molecules.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890821      PMCID: PMC1770035          DOI: 10.1136/jcp.56.8.631

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes.

Authors:  P Anderson; C Nagler-Anderson; C O'Brien; H Levine; S Watkins; H S Slayter; M L Blue; S F Schlossman
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

Review 2.  Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature.

Authors:  W A Khan; L Yu; A B Eisenbrey; D Crisan; A al Saadi; B H Davis; R C Hankin; J C Mattson
Journal:  Am J Clin Pathol       Date:  2001-07       Impact factor: 2.493

3.  Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation.

Authors:  K E Salhany; M Feldman; M J Kahn; D Peritt; R D Schretzenmair; D M Wilson; R S DiPaola; A D Glick; J A Kant; P C Nowell; M Kamoun
Journal:  Hum Pathol       Date:  1997-06       Impact factor: 3.466

4.  Comparative ultrastructural study of cytotoxic granules in nasal natural killer cell lymphoma, intestinal T-cell lymphoma, and anaplastic large cell lymphoma.

Authors:  Y Sadahira; K Akisada; T Sugihara; S Hata; K Uehira; N Muraki; T Manabe
Journal:  Virchows Arch       Date:  2001-03       Impact factor: 4.064

5.  Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas.

Authors:  W R Macon; N B Levy; P J Kurtin; K E Salhany; M Y Elkhalifa; T T Casey; F E Craig; C L Vnencak-Jones; M L Gulley; J P Park; J B Cousar
Journal:  Am J Surg Pathol       Date:  2001-03       Impact factor: 6.394

6.  Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules.

Authors:  K Ohshima; S Haraoka; N Harada; T Kamimura; J Suzumiya; M Kanda; C Kawasaki; M Sugihara; M Kikuchi
Journal:  Histopathology       Date:  2000-02       Impact factor: 5.087

7.  Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.

Authors:  C B Cooke; L Krenacs; M Stetler-Stevenson; T C Greiner; M Raffeld; D W Kingma; L Abruzzo; C Frantz; M Kaviani; E S Jaffe
Journal:  Blood       Date:  1996-12-01       Impact factor: 22.113

8.  Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta.

Authors:  J P Farcet; P Gaulard; J P Marolleau; J P Le Couedic; T Henni; M F Gourdin; M Divine; C Haioun; S Zafrani; M Goossens
Journal:  Blood       Date:  1990-06-01       Impact factor: 22.113

9.  Peripheral T-cell lymphoma presenting as predominant liver disease: a report of three cases.

Authors:  P Gaulard; E S Zafrani; P Mavier; F D Rocha; J P Farcet; M Divine; C Haioun; Y Pinaudeau
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

10.  Expression of cytotoxic molecule TIA-1 in malignant lymphomas mimicking fulminant hepatitis.

Authors:  Y Sadahira; K Ohmoto; S Yamamoto; H Nishihara; H Wada; Y Yawata; T Manabe
Journal:  Pathol Int       Date:  1998-09       Impact factor: 2.534

  10 in total
  1 in total

1.  Hepatosplenic T cell lymphoma: a rare case report.

Authors:  Monalisa Hui; Shantveer G Uppin; Tara Roshni Paul; N Beerappa
Journal:  Indian J Hematol Blood Transfus       Date:  2012-12-18       Impact factor: 0.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.